Qvt Financial LP Roivant Sciences Ltd. Transaction History
Qvt Financial LP
- $1.02 Billion
- Q2 2025
A detailed history of Qvt Financial LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Qvt Financial LP holds 29,381,635 shares of ROIV stock, worth $340 Million. This represents 32.33% of its overall portfolio holdings.
Number of Shares
29,381,635
Previous 65,793,779
55.34%
Holding current value
$340 Million
Previous $664 Million
50.12%
% of portfolio
32.33%
Previous 69.8%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
363Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$694 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$517 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$396 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...